{
  "trial_id": "NCT00917267",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, body mass index (BMI), duration of type 2 diabetes, baseline HbA1c, prior diabetes medication regimen, ethnicity, baseline fasting plasma glucose, baseline postprandial glucose, baseline blood pressure, baseline lipid profile (total cholesterol, LDL, HDL, triglycerides), baseline renal function (serum creatinine, eGFR), baseline liver function tests (ALT, AST), baseline weight, smoking status, alcohol consumption.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Glycosylated hemoglobin (HbA1c)",
          "baseline HbA1c"
        ],
        [
          "Weight",
          "baseline weight"
        ],
        [
          "Background Oral Antidiabetic Agent (OAD)",
          "prior diabetes medication regimen"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "ethnicity",
        "baseline fasting plasma glucose",
        "baseline postprandial glucose",
        "baseline blood pressure",
        "baseline lipid profile (total cholesterol, LDL, HDL, triglycerides)",
        "baseline renal function (serum creatinine, eGFR)",
        "baseline liver function tests (ALT, AST)",
        "smoking status",
        "alcohol consumption"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Prior Diabetes Medications, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose, Weight,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Glycosylated hemoglobin (HbA1c)",
          "Baseline HbA1c"
        ],
        [
          "Weight",
          "Weight"
        ],
        [
          "Background Oral Antidiabetic Agent (OAD)",
          "Prior Diabetes Medications"
        ]
      ],
      "remaining_reference_features": [
        "Categorical"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Duration of Diabetes",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Fasting Plasma Glucose"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, HbA1c, Diabetes duration, Previous treatment with oral antidiabetic drugs, Systolic Blood Pressure, Diastolic Blood Pressure.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Glycosylated hemoglobin (HbA1c)",
          "HbA1c"
        ],
        [
          "Background Oral Antidiabetic Agent (OAD)",
          "Previous treatment with oral antidiabetic drugs"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Diabetes duration",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c at baseline, fasting plasma glucose at baseline, systolic blood pressure, diastolic blood pressure, heart rate, history of hypertension, history of cardiovascular disease, history of microvascular complications, current medications, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Glycosylated hemoglobin (HbA1c)",
          "HbA1c at baseline"
        ],
        [
          "Background Oral Antidiabetic Agent (OAD)",
          "current medications"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Weight"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "fasting plasma glucose at baseline",
        "systolic blood pressure",
        "diastolic blood pressure",
        "heart rate",
        "history of hypertension",
        "history of cardiovascular disease",
        "history of microvascular complications",
        "smoking status"
      ]
    }
  }
}